Johnson & Johnson said it will include the list price of its drugs and their potential out-of-pocket costs in direct-to-consumer television advertisements starting next month. The move makes J&J the first drugmaker to act on the Trump administration's call for drug price transparency in TV ads, and the company's blood thinner Xarelto, which costs around $450 to $540 per month, will be the first TV ad to include pricing details.
Sign up for Specialty Pharmacy SmartBrief
News affecting the specialty pharmacy industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.